No role for estrogen receptor I gene intron I Pvu II and exon 4 C325G polymorphisms in migraine susceptibility

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Colson, Natalie J ^a   Lea, Rod A ^a,b   Quinlan, Sharon ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PYRIMIDINE NUCLEOTIDE; ESTROGEN RECEPTOR ALPHA;

ARTICLE; CASE CONTROL STUDY; CHI SQUARE TEST; CONTINGENCY TABLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MIGRAINE; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; GENETIC PREDISPOSITION; GENETICS;

CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; MIGRAINE DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33645637216     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-12     Document Type: Article

References (44)

1. WHO: The World Health Report. Mental Health: New Understanding, New Hope. [http://www.who.int/whr2001/].
2. Montagna P: Molecular genetics of migraine headaches: a review. Cephalalgia 2000, 20:3-14.
3. Ophoff RA, van den Maagdenberg AM, Roon KI, Ferrari MD, Frants RR: The impact of pharmacogenetics for migraine. Eur J Pharmacol 2001, 413:1-10.
4. Peroutka SJ: Sympathetic look at genetic basis of migraine. Headache 2002, 42:378-381.
5. Kowa H, Fusayasu E, Ijiri T, Ishizaki K, Yasui K, Nakaso K, Kusumi M, Takeshima T, Nakashima K: Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett 2005, 374:129-131.
6. Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR: Investigation of hormone receptor genes in migraine. Neurogenetics 2005, 6:17-23.
7. Marziniak M, Mossner R, Schmitt A, Lesch KP, Sommer C: A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology 2005, 64:157-159.
8. Lea RA, Ovcaric M, Sundholm J, Solyom L, Macmillan J, Griffiths LR: Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res 2005, 136:112-117.
9. McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR, Peroutka SJ, Griffiths LR, Boyd PR, Lea RA, Bhatti SM, Hosking LK, Hood CM, Jones KW, Handley AR, Rallan R, Lewis KF, Yeo AJ, Williams PM, Priest RC, Khan P, Donnelly C, Lumsden SM, O'Sullivan J, See CG, Smart DH, Shaw-Hawkins S, Patel J, Langrish TC, Feniuk W, Knowles RG, Thomas M, Libri V, Montgomery DS, Manasco PK, Xu CF, Dykes C, Humphrey PP, Roses AD, Purvis IJ: Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 2001, 78:135-149.
10. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K: The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000, 96:762-764.
11. Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR: Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 2000, 3:35-40.
12. Paterna S, Di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A, Maniscalchi T, Follone G, Giubilato A, Tarantello M, Licata G: Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 2000, 43:133-136.
13. Del Zompo M, Cherchi A. Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP: Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998, 51:781-786.
14. Ogilvie AD, Russell MB, Dhall P, Battersby S, Ulrich V, Smith CA, Goodwin GM, Harmar AJ, Olesen J: Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 1998, 18:23-26.
15. Peroutka SJ, Wilhoit T, Jones K: Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) Ncol alleles. Neurology 1997, 49:201-206.
16. MacGregor EA: Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004, 3:354-361.
17. Epstein MT, Hockaday JM, Hockaday TD: Migraine and reporoductive hormones throughout the menstrual cycle. Lancet 1975, 1:543-548.
18. Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR: The estrogen receptor I G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004, 5:129-133.
19. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, Zillikens MC, Hofman A, van Leeuwen JP, Pols HA, Uitterlinden AG: Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 2005, 153:327-334.
20. Shearman AM, Cooper JA, Kotwinski PJ, Humphries SE, Mendelsohn ME, Housman DE, Miller GJ: Estrogen receptor alpha gene variation and the risk of stroke. Stroke 2005, 36:2281-2282.
21. Diener HC, Kurth T: Is migraine a risk factor for stroke? Neurology 2005, 64:1496-1497.
22. Hoshino S, Hosoi T, Miyao M, Shiraki M, Orimo H, Ouchi Y, Inoue S: Identification of a novel polymorphism of estrogen receptor-alpha gene that is associated with calcium excretion in urine. J Bone Miner Metab 2000, 18:153-157.
23. Vasconcelos A, Medeiros P. Veiga. I, Pereira D, Carrilho S, Palmeira C, Azevedo C, Lopes CS: Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis. Breast J 2002, 8:226-229.
24. Hsiao WC, Young KC, Lin SL, Lin PW: Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Breast Cancer Res 2004, 6:RI80-6.
25. Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR: Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 2001, 95:271-275.
26. Sasaki M, Tanaka Y, Sakuragi N, Dahiya R: Six polymorphisms on estrogen receptor I gene in Japanese, American and German populations. Eur J Clin Pharmacol 2003, 59:389-393.
27. Johnson MP, Lea RA, Curtain RP, MacMillan JC, Griffiths LR: An investigation of the 5-HT2C receptor gene as a migraine candidate gene. Am J Med Genet 2003, 117B:86-89.
28. Lea RA, Curtain RP, Hutchins C, Brimage PJ, Griffiths LR: Investigation of the CACNAIA gene as a candidate for typical migraine susceptibility. Am J Med Genet 2001, 105:707-712.
29. HCCIHS: Headache Classification Committee for the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain 1st edition. Cephalgio 1988, 8 (Suppl 7):1-96.
30. Lai IC, Liao DL, Bai YM, Lin CC, Yu SC, Chen JY, Wang YC: Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia. Neuropsychobiology 2002, 46:173-175.
31. Iwase H, Greenman JM, Barnes DM, Hodgson S, Bobrow L, Mathew CG: Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors. Cancer Lett 1996, 108:179-184.
32. Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. Bmj 2005, 330:63.
33. Schwaag S, Nabavi DG, Frese A, Husstedt IW, Evers S: The association between migraine and juvenile stroke: a case-control study. Headache 2003, 43:90-95.
34. Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N: Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997, 54:362-368.
35. Donaghy M, Chang CL, Poulter N: Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002, 73:747-750.
36. Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, Clamp M, Clarke L, Coates G, Cox T, Cunningham F, Curwen V, Cutts T, Down T, Durbin R, Fernandez-Suarez XM, Gilbert J, Hammond M, Herrero J, Hotz H, Howe K, Iyer V, Jekosch K, Kahari A, Kasprzyk A, Keefe D, Keenan S, Kokocinsci F, London D, Longden I, McVicker G, Melsopp C, Meidl P, Potter S, Proctor G, Rae M, Rios D, Schuster M, Searle S, Severin J, Slater G, Smedley D, Smith J, Spooner W, Stabenau A, Stalker J, Storey R, Trevanion S, Ureta-Vidal A, Vogel J, White S, Woodwark C, Birney E: Ensembl 2005. Nucleic Acids Res 2005, 33:D447-53.
37. Osterlund MK, Grandien K, Keller E, Hurd YL: The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J Neurochem 2000, 75:1390-1397.
38. Mize AL, Shapiro RA, Dorsa DM: Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 2003, 144:306-312.
39. McEwen B: Estrogen actions throughout the brain. Recent Prog Horm Res 2002, 57:357-384.
40. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW: Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 1991, 254:1636-1639.
41. Kelly MJ, Levin ER: Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 2001, 12:152-156.
42. Simoncini T, Hafezi-Moghadam A, Brazil D, Ley K, Chin W, Liao J: Interaction of estrogen receptor with regulatory subunit of phosphatidylinositol-OH kinase. Nature 2000, 407:
43. Diel P: Tissue-specific estrogenic response and molecular mechanisms. Toxicol Lett 2002, 127:217-224.
44. Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvanen AC, Kindmark A, Landegren U, Fermer ML, Stiger F, Persson I, Baron J, Weiderpass E: Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. Breast Cancer Res 2004, 6:R437-49.